217 related articles for article (PubMed ID: 30593524)
1. Activation of Estrogen Receptor Alpha by Decitabine Inhibits Osteosarcoma Growth and Metastasis.
Lillo Osuna MA; Garcia-Lopez J; El Ayachi I; Fatima I; Khalid AB; Kumpati J; Slayden AV; Seagroves TN; Miranda-Carboni GA; Krum SA
Cancer Res; 2019 Mar; 79(6):1054-1068. PubMed ID: 30593524
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Estrogen Receptor Alpha Inhibits Cell Proliferation, Differentiation and Enhances the Chemosensitivity of P53-Positive U2OS Osteosarcoma Cell.
Wang JY; Chen CM; Chen CF; Wu PK; Chen WM
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681897
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and estrogen receptor alpha promotes malignancy and osteoblastic tumorigenesis in prostate cancer.
Mishra S; Tai Q; Gu X; Schmitz J; Poullard A; Fajardo RJ; Mahalingam D; Chen X; Zhu X; Sun LZ
Oncotarget; 2015 Dec; 6(42):44388-402. PubMed ID: 26575018
[TBL] [Abstract][Full Text] [Related]
4. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
[TBL] [Abstract][Full Text] [Related]
5. Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?
Kendal JK; Singla A; Affan A; Hildebrand K; Al-Ani A; Ungrin M; Mahoney DJ; Itani D; Jirik FR; Monument MJ
Clin Orthop Relat Res; 2020 Dec; 478(12):2921-2933. PubMed ID: 33275394
[TBL] [Abstract][Full Text] [Related]
6. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y
Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153
[TBL] [Abstract][Full Text] [Related]
7. 17β-estradiol regulates cell proliferation, colony formation, migration, invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner.
Fang D; Yang H; Lin J; Teng Y; Jiang Y; Chen J; Li Y
Biochem Biophys Res Commun; 2015 Feb; 457(4):500-6. PubMed ID: 25592968
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma.
Liao D; Zhong L; Yin J; Zeng C; Wang X; Huang X; Chen J; Zhang H; Zhang R; Guan XY; Shuai X; Sui J; Gao S; Deng W; Zeng YX; Shen JN; Chen J; Kang T
Nat Cell Biol; 2020 Jul; 22(7):868-881. PubMed ID: 32483387
[TBL] [Abstract][Full Text] [Related]
9. Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells
Wang Z; Wang Z; Li S; Li B; Sun L; Li H; Lin P; Wang S; Teng W; Zhou X; Ye Z
Front Immunol; 2018; 9():1239. PubMed ID: 29910819
[TBL] [Abstract][Full Text] [Related]
10. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor necrosis factor therapy inhibits lung metastasis in an osteosarcoma cell line.
Kato H; Wakabayashi H; Naito Y; Kato S; Nakagawa T; Matsumine A; Sudo A
Oncology; 2015; 88(3):139-46. PubMed ID: 25402182
[TBL] [Abstract][Full Text] [Related]
12. PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma.
Li W; Zhang X; Xi X; Li Y; Quan H; Liu S; Wu L; Wu P; Lan W; Shao Y; Li H; Chen K; Hu Z
Cancer Med; 2020 Jun; 9(12):4371-4385. PubMed ID: 32349184
[TBL] [Abstract][Full Text] [Related]
13. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619.
Lavaud M; Mullard M; Tesfaye R; Amiaud J; Legrand M; Danieau G; Brion R; Morice S; Regnier L; Dupuy M; Brounais-Le Royer B; Lamoureux F; Ory B; Rédini F; Verrecchia F
Cells; 2021 Aug; 10(9):. PubMed ID: 34571917
[TBL] [Abstract][Full Text] [Related]
16. Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma.
Li B; Zhu X; Sun L; Yuan L; Zhang J; Li H; Ye Z
Oncotarget; 2014 Nov; 5(21):10791-802. PubMed ID: 25301731
[TBL] [Abstract][Full Text] [Related]
17. Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment.
Sirianni R; Zolea F; Chimento A; Ruggiero C; Cerquetti L; Fallo F; Pilon C; Arnaldi G; Carpinelli G; Stigliano A; Pezzi V
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2238-50. PubMed ID: 23074235
[TBL] [Abstract][Full Text] [Related]
18. HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy.
La Noce M; Paino F; Mele L; Papaccio G; Regad T; Lombardi A; Papaccio F; Desiderio V; Tirino V
J Exp Clin Cancer Res; 2018 Dec; 37(1):296. PubMed ID: 30509303
[TBL] [Abstract][Full Text] [Related]
19. Methylation of the ER-alpha Promoter Is Influenced by its Ligand Estrogen in Osteosarcoma Cells SAOS-2 In Vitro.
Tübel J; Kuntz L; Marthen C; Schmitt A; Wiest I; VON Eisenhart-Rothe R; Jeschke U; Burgkart R
Anticancer Res; 2016 Jun; 36(6):3199-204. PubMed ID: 27272849
[TBL] [Abstract][Full Text] [Related]
20. p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.
Li Y; Nakka M; Kelly AJ; Lau CC; Krailo M; Barkauskas DA; Hicks JM; Man TK
Cancer Res; 2016 Jul; 76(13):4002-11. PubMed ID: 27197201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]